PMDA drug package insert
エドスチラドリン膀胱内注入液
PMDA Regenerative medical product · フェリング・ファーマ株式会社 · package insert Jul 15, 2026
Key facts
| Brand names | エドスチラドリン膀胱内注入液 |
|---|---|
| Nonproprietary names | ナドファラゲン フィラデノベク |
| Companies | 製造販売元／フェリング・ファーマ株式会社 |
| Product type | Regenerative medical product |
| Package insert date | Jul 15, 2026 |
| PMDA document key | 670666_4900702X1025_A_01 |
| PMDA company code | 670666 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: